GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » EBITDA Margin %

Tenon Medical (Tenon Medical) EBITDA Margin % : -470.38% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tenon Medical's EBITDA for the three months ended in Mar. 2024 was $-3.38 Mil. Tenon Medical's Revenue for the three months ended in Mar. 2024 was $0.72 Mil. Therefore, Tenon Medical's EBITDA margin for the quarter that ended in Mar. 2024 was -470.38%.


Tenon Medical EBITDA Margin % Historical Data

The historical data trend for Tenon Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical EBITDA Margin % Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
-1,222.73 -3,966.25 -2,644.57 -516.87

Tenon Medical Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,097.00 -564.47 -341.53 -367.08 -470.38

Competitive Comparison of Tenon Medical's EBITDA Margin %

For the Medical Devices subindustry, Tenon Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenon Medical's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tenon Medical's EBITDA Margin % falls into.



Tenon Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tenon Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15.134/2.928
=-516.87 %

Tenon Medical's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.382/0.719
=-470.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenon Medical  (NAS:TNON) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tenon Medical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tenon Medical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenon Medical (Tenon Medical) Business Description

Traded in Other Exchanges
N/A
Address
104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Executives
Van Dick Steven M officer: Chief Financial Officer HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn director, officer: Chief Technology Officer 104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster director, officer: CEO and President 104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler director C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer director 9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari director 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard director 104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle director 104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke 10 percent owner ZURCHERSTRASSE 39J, SCHLIEREN V8 8952